AC
Armistice Capital Portfolio holdings
AUM
$2.64B
This Quarter Return
+0.39%
1 Year Return
+0.99%
3 Year Return
+16.29%
5 Year Return
+18.04%
10 Year Return
+34.8%
AUM
$2.64B
AUM Growth
+$2.64B
(-30%)
Cap. Flow
-$1.17B
Cap. Flow
% of AUM
-44.32%
Top 10 Holdings %
Top 10 Hldgs %
37.78%
Holding
281
New
59
Increased
39
Reduced
77
Closed
79
Top Buys
| 1 |
GE HealthCare
GEHC
|
$33.6M |
| 2 |
McDonald's
MCD
|
$30.3M |
| 3 |
ImmunityBio
IBRX
|
$20.5M |
| 4 |
GitLab
GTLB
|
$14.6M |
| 5 |
MongoDB
MDB
|
$12.3M |
Top Sells
| 1 |
Exact Sciences
EXAS
|
$54.8M |
| 2 |
Spectrum Brands
SPB
|
$49.4M |
| 3 |
Simply Good Foods
SMPL
|
$46.6M |
| 4 |
Sensient Technologies
SXT
|
$43.9M |
| 5 |
FibroGen
FGEN
|
$43.3M |
Sector Composition
| 1 | Healthcare | 69.03% |
| 2 | Consumer Discretionary | 12.86% |
| 3 | Technology | 10.97% |
| 4 | Consumer Staples | 3.25% |
| 5 | Communication Services | 2.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
RH
RH
$4.23B
| $4.21M | 0.07% | 22,292 -50,274 | -69% | -$9.5M |
|
102
Wynn Resorts
WYNN
$13.2B
| $4.2M | 0.07% | +44,857 | New | +$4.2M |
|
103
Arvinas
ARVN
$568M
| $4.12M | 0.07% | +560,000 | New | +$4.12M |
|
104
Deckers Outdoor
DECK
$17.7B
| $3.97M | 0.07% | 38,516 -42,970 | -53% | -$4.43M |
|
105
Amer Sports
AS
$21.8B
| $3.93M | 0.07% | 101,309 -7,685 | -7% | -$298K |
|
106
Alto Neuroscience
ANRO
$99.6M
| $3.57M | 0.06% | 1,624,000 +24,000 | +2% | +$52.8K |
|
107
Levi Strauss
LEVI
$8.85B
| $3.51M | 0.06% | 190,000 -30,000 | -14% | -$555K |
|
108
Best Buy
BBY
$15.6B
| $3.31M | 0.06% | 49,373 -22,771 | -32% | -$1.53M |
|
109
AstraZeneca
AZN
$248B
| $3.28M | 0.06% | 47,000 +23,000 | +96% | +$1.61M |
|
110
Mobix Labs
MOBX
$64.8M
| $3.27M | 0.06% | +4,276,000 | New | +$3.27M |
|
111
Glaukos
GKOS
$5.5B
| $3.25M | 0.06% | +31,438 | New | +$3.25M |
|
112
Nektar Therapeutics
NKTR
$568M
| $3.2M | 0.06% | 124,000 -912,000 | -88% | -$23.6M |
|
113
Vera Therapeutics
VERA
$1.38B
| $3.2M | 0.06% | 136,000 -164,000 | -55% | -$3.86M |
|
114
Eli Lilly
LLY
$657B
| $3.04M | 0.05% | 3,898 +3,583 | +1,137% | +$2.79M |
|
115
PDS Biotechnology
PDSB
$57.8M
| $2.97M | 0.05% | 2,236,000 -2,183,000 | -49% | -$2.9M |
|
116
AvePoint
AVPT
$3.47B
| $2.9M | 0.05% | +150,000 | New | +$2.9M |
|
117
Victoria's Secret
VSCO
$1.84B
| $2.87M | 0.05% | 155,000 +35,000 | +29% | +$648K |
|
118
LivaNova
LIVN
$3.08B
| $2.75M | 0.05% | +61,000 | New | +$2.75M |
|
119
Crocs
CROX
$4.76B
| $2.6M | 0.04% | +25,685 | New | +$2.6M |
|
120
Spyre Therapeutics
SYRE
$996M
| $2.57M | 0.04% | 172,000 -28,000 | -14% | -$419K |
|
121
Mineralys Therapeutics
MLYS
$1.03B
| $2.41M | 0.04% | +178,000 | New | +$2.41M |
|
122
Capri Holdings
CPRI
$2.45B
| $2.39M | 0.04% | 135,000 | – | – |
|
123
BJ's Restaurants
BJRI
$742M
| $2.23M | 0.04% | 50,000 | – | – |
|
124
Conduent
CNDT
$439M
| $2.21M | 0.04% | +836,000 | New | +$2.21M |
|
125
Spotify
SPOT
$140B
| $2.16M | 0.04% | 2,816 -2,243 | -44% | -$1.72M |
|